J&J(JNJ) - 2025 Q2 - Earnings Call Transcript
Johnson & Johnson (JNJ) Q2 2025 Earnings Call July 16, 2025 08:30 AM ET Company Participants Darren Snellgrove - VP - IR Joaquin Duato - CEO, Chairman & Director Joseph Wolk - EVP & CFO Chris Schott - Managing Director Jennifer Taubert - EVP & Worldwide Chairman - Innovative Medicine Tim Schmid - EVP & Worldwide Chairman - MedTech John Reed - EVP - Innovative Medicine & R&D Alexandria Hammond - Director - Head of Therapeutics Conference Call Participants Terence Flynn - Equity Research Analyst Lawrence Bieg ...